Bio-Rad Laboratories (BIO-B) EPS (Weighted Average and Diluted) (2009 - 2026)
Bio-Rad Laboratories (BIO-B) reported EPS (Weighted Average and Diluted) of -$19.55 for Q1 2026, down 953.71% year-over-year from $2.29 in Q1 2025, and down 174.08% on a QoQ basis from $26.39 in Q4 2025.
Bio-Rad Laboratories (BIO-B) has 18 years of EPS (Weighted Average and Diluted) data on file, last reported at -$19.55 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) fell 953.71% year-over-year to -$19.55 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.81 (up 107.62% YoY) and the FY2025 annual result came in at $27.85, up 142.61% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$19.55 in Q1 2026 per BIO-B's latest filing, from $26.39 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $27.78 in Q4 2022 and bottomed at -$112.5 in Q1 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is $2.29 (2025), against an average of -$11.75.
- The widest annual swing landed in 2024, when EPS (Weighted Average and Diluted) surged 541.21%; it then slumped 953.71% in 2026.
- Tracing BIO-B's EPS (Weighted Average and Diluted) over 5 years: stood at $27.78 in 2022, then plunged by 56.3% to $12.14 in 2023, then tumbled by 310.63% to -$25.57 in 2024, then surged by 203.21% to $26.39 in 2025, then slumped by 174.08% to -$19.55 in 2026.
- Per Business Quant, the three latest BIO-B EPS (Weighted Average and Diluted) figures stand at -$19.55 (Q1 2026), $26.39 (Q4 2025), and -$12.7 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | -19.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.55 |
| Dec 31, 2025 | 26.39 |
| Sep 30, 2025 | -12.70 |
| Jun 30, 2025 | 11.67 |
| Mar 31, 2025 | 2.29 |
| Dec 31, 2024 | -25.57 |
| Sep 30, 2024 | 23.34 |
| Jun 30, 2024 | -76.26 |
| Mar 31, 2024 | 13.45 |
| Dec 31, 2023 | 12.14 |
| Sep 30, 2023 | 3.64 |
| Jun 30, 2023 | -39.59 |
| Mar 31, 2023 | 2.32 |
| Dec 31, 2022 | 27.78 |
| Sep 30, 2022 | -5.48 |
| Jun 30, 2022 | -31.05 |
| Mar 31, 2022 | -112.50 |
| Dec 31, 2021 | -52.54 |
| Sep 30, 2021 | 130.02 |
| Jun 30, 2021 | 30.41 |
| Mar 31, 2021 | 32.46 |
| Dec 31, 2020 | 27.81 |
| Sep 30, 2020 | 43.64 |
| Jun 30, 2020 | 32.15 |
| Mar 31, 2020 | 22.72 |
| Dec 31, 2019 | 18.31 |
| Sep 30, 2019 | -8.68 |
| Jun 30, 2019 | 19.86 |
| Mar 31, 2019 | 28.74 |
| Dec 31, 2018 | -27.73 |
| Sep 30, 2018 | 8.89 |
| Jun 30, 2018 | 8.87 |
| Mar 31, 2018 | 21.77 |
| Dec 31, 2017 | 2.75 |
| Sep 30, 2017 | 0.73 |
| Jun 30, 2017 | 0.17 |
| Mar 31, 2017 | 0.41 |
| Dec 31, 2016 | -0.63 |
| Sep 30, 2016 | 0.58 |
| Jun 30, 2016 | 0.56 |
| Mar 31, 2016 | 0.37 |
| Dec 31, 2015 | 1.68 |
| Sep 30, 2015 | 0.59 |
| Jun 30, 2015 | 0.97 |
| Mar 31, 2015 | 0.61 |
| Dec 31, 2014 | 1.34 |
| Sep 30, 2014 | 0.39 |
| Jun 30, 2014 | 1.09 |
| Mar 31, 2014 | 0.23 |
| Dec 31, 2013 | 1.04 |
| Sep 30, 2013 | -0.25 |
| Jun 30, 2013 | 1.20 |
| Mar 31, 2013 | 0.70 |
| Dec 31, 2012 | 1.51 |
| Sep 30, 2012 | 0.01 |
| Jun 30, 2012 | 1.68 |
| Mar 31, 2012 | 0.01 |
| Dec 31, 2011 | 2.08 |
| Sep 30, 2011 | 1.61 |
| Jun 30, 2011 | 1.41 |
| Mar 31, 2011 | 1.16 |
| Dec 31, 2010 | 2.41 |
| Sep 30, 2010 | 1.59 |
| Jun 30, 2010 | 1.35 |
| Mar 31, 2010 | 1.24 |
| Dec 31, 2009 | 1.35 |
| Sep 30, 2009 | 1.38 |
| Jun 30, 2009 | 1.37 |